InvestorsHub Logo
Followers 4
Posts 753
Boards Moderated 0
Alias Born 04/18/2017

Re: None

Friday, 10/18/2019 2:53:26 PM

Friday, October 18, 2019 2:53:26 PM

Post# of 54907
Let's put things in perspective. The poop test company (only one product on market) EXAS has a market cap and enterprise value north of $12B (well off it's 52 week highs). Their projected sales for 2019 are $812M. Their TTM sales are $623M. That means their current stock price is 20 times TTM sales. BTW they are losing money every year. Their EBITDA for TTM is negative $124M.

If PRED can do $300M in sales in 2020, it's stock price could be $20 per share if using the same multiple times sales. Would you be happy with that price at this point? I would!